Hepatic transit time of ultrasound contrast in biopsy characterized liver disease

Acta Radiologica

Volumn 46, Issue 6, 2005, Pages 557-560

  Pedersen, J F ^a,b   Larsen, V A ^a   Bytzer, P ^a   Madsen, L G ^a   Hamberg, O ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cirrhosis; Transit time; Ultrasound contrast

Indexed keywords

BIOLOGICAL ORGANS; BIOPSY; DISEASES; ULTRASONICS;

CIRRHOSIS; TRANSIT TIME; ULTRASOUND CONTRAST;

CONTRAST MEDIA;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; POLYSACCHARIDE; SHU 508;

ARTICLE; BIOPSY; ECHOGRAPHY; ELBOW; FEMALE; HEPATIC ARTERY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER; LIVER CIRRHOSIS; LIVER DISEASE; LIVER VEIN; MALE; METABOLISM; MIDDLE AGED; PORTAL VEIN; SINGLE BLIND PROCEDURE; TIME; VASCULARIZATION; VIDEORECORDING;

BIOPSY; CONTRAST MEDIA; ELBOW; FEMALE; HEPATIC ARTERY; HEPATIC VEINS; HUMANS; INJECTIONS, INTRAVENOUS; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; MALE; MIDDLE AGED; POLYSACCHARIDES; PORTAL VEIN; SINGLE-BLIND METHOD; TIME FACTORS; VIDEOTAPE RECORDING;

EID: 33644665652     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850510021689     Document Type: Article

References (12)

1. Albrecht T, Blomley MJK, Cosgrove DO, Taylor Robinson SD, Jayaram V, Eckersley R, et al. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet 1999;353:1579-83.
2. Bang N, Nielsen MB, Rasmussen AN, Osterhammel PA, Pedersen JF. Hepatic vein transit time of an ultrasound contrast agent: simplified procedure using pulse inversion imaging. Br J Radiol 2001;74:752-5.
3. Bernatik T, Becker D, Neureiter D, Hänsler J, Frieser M, Schaber S, et al. Hepatic transit time of an echo enhancer: an indicator of metastatic spread to the liver. Eur J Gastroenterol Hepatol 2004;16:313-17.
4. Blomley M, Albrecht T, Cosgrove DO, Jayaram V, Eckersley RJ, Patel N, et al. Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: early experience in seven patients with metastases. Radiology 1998;209:862-6.
5. Blomley MJK, Lim AKP, Harvey CJ, Patel N, Eckersley RJ, Basilico R. Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross-sectional study. GUT 2003;52: 1188-93.
6. Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. GUT 1995;36:437-41.
7. Giuseppetti GM, Argalia G, Abbattista T. Liver cirrhosis: evaluation of haemodynamic changes using an ultrasound contrast agent. Eur J Radiol 2004;51: 27-33.
8. Nord JH. Biopsy diagnosis of cirrhosis: blind percutaneous versus guided direct vision technique (Review). Gastrointest Endosc 1982;28:102-4.
9. Ohnishi K, Chin N, Saito M, Tanaka H, Terabayashi H, Nakayama T, et al. Portographic opacification of hepatic veins and (anomalous) anastomoses between the portal and hepatic veins in cirrhosis - indication of extensive intrahepatic shunts. Am J Gastroenterol 1986;81:975-8.
10. Popper H, Elias H, Petty DE. Vascular pattern of the cirrhotic liver. Am J Clin Path 1952;22:717-29.
11. Reynaert H, Thompson MG, Thomas T, Geerts A. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. GUT 2002;50:571-81.
12. Sugimoto H, Kaneko T, Hirota M, Tezel E, Nakao A. Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis. J Hepatol 2002;37:578-83.